Plus Therapeutics, Inc. (PSTV)
NASDAQ: PSTV · Real-Time Price · USD
0.4914
+0.0417 (9.27%)
At close: Sep 5, 2025, 4:00 PM
0.4950
+0.0036 (0.73%)
After-hours: Sep 5, 2025, 7:59 PM EDT

Plus Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202016 - 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2020
4978111610
Upgrade
Market Cap Growth
111.53%-14.33%-25.69%-33.96%67.05%6.69%
Upgrade
Enterprise Value
4251-429
Upgrade
Last Close Price
0.491.151.754.7515.7530.30
Upgrade
PS Ratio
1.491.161.6147.55-31.86
Upgrade
PB Ratio
14.93-0.76-5.871.651.493.19
Upgrade
P/TBV Ratio
21.57--1.781.553.75
Upgrade
EV/Sales Ratio
7.890.930.30--29.48
Upgrade
Debt / Equity Ratio
0.01-0.38-3.100.880.652.31
Upgrade
Asset Turnover
0.490.650.280.01-0.02
Upgrade
Quick Ratio
1.080.270.801.533.140.98
Upgrade
Current Ratio
1.260.340.921.843.361.07
Upgrade
Return on Equity (ROE)
---522.50%-234.65%-193.25%-393.27%
Upgrade
Return on Assets (ROA)
-74.05%-101.93%-47.23%-53.74%-44.65%-31.14%
Upgrade
Return on Capital (ROIC)
---111.58%-82.36%-54.64%-47.49%
Upgrade
Earnings Yield
-39.01%-191.39%-168.24%-190.35%-83.08%-85.36%
Upgrade
FCF Yield
-34.64%-157.80%-164.38%-126.56%-64.63%-88.32%
Upgrade
Buyback Yield / Dilution
-248.04%-145.18%-79.45%-117.18%-173.03%-219.93%
Upgrade
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q